Evaluating the effect of a Combined exercise Program on muscle structure and fitness for daily activities in older adults with Type 2 Diabetes

INTERVENTION: Intervention1: Concurrent Exercise Program: Participants in the intervention group will be receiving a supervised concurrent exercise program comprising aerobic, resistance, and balance training, along with standard care for 12 weeks, which is followed by 12 weeks of maintenance phase. Exercise sessions will be conducted three to five times a week under the supervision of a qualified physiotherapist for 1 to 2 weeks. After the 2nd week, there will be home‐based exercises with supervised exercise once in a 2 weeks. Each session will include 5‐10 minutes of warm up session, followed by Concurrent Exercise Program, and will conclude with a 5‐10‐minute cool‐down and relaxation techniques such as breathing exercises. Control Intervention1: Standard Care: In standard care patients will receive basic education regarding fall risk prevention, the importance of maintaining regular physical activity and adherence to prescribed medication and diet CONDITION: Health Condition 1: E119‐ Type 2 diabetes mellitus without complications PRIMARY OUTCOME: Thickness (mm) and cross‐sectional area of muscle(cm2) using Muscle ultrasound imaging ; Functional Fitness using Senior Fitness TestTimepoint: Muscle ultrasound imaging will be assessed at two time points, at baseline and at 24th week. ; ; Senior Fitness Test will be assessed at three time points, at baseline, at 12th week and at 24th week SECONDARY OUTCOME: Skeletal muscle mass (Kg): Bioelectrical Impedance Analyser (BIA) ; Glycemic parameter (%): HbA1c ; Human Telomerase Reverse Transcriptase (hTERT) protein(ng/mL) ‐using Sandwich Enzyme ; Linked Immunosorbent Assay ; Fall risk: Falls Efficacy Scale‐ InternationalTimepoint: Bioelectrical Impedance Analyser (BIA) will be assessed at three time points, at baseline, at 12th week and at 24th week ; ; HbA1c levels will be noted at two time points, at baseline and at 24th week ; ; Sandwich Enzyme ; Linked Immunosorbent Assay will be assessed at 2 time points at baseline and at 24th week ; ; Falls Efficacy Scale‐ International mpedance Analyser (BIA) will be assessed at three time points, at baseline, at 12th week and at 24th week INCLUSION CRITERIA: ‐Age between 60 to 75 years ‐Either Gender ‐Diagnosed with Type 2 Diabetes Mellitus for atleast one year on diabetic medication (including oral hypoglycemic agents and/or insulin)